Redmile Group as of Dec. 31, 2017
Portfolio Holdings for Redmile Group
Redmile Group holds 69 positions in its portfolio as reported in the December 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Array BioPharma | 10.7 | $245M | 19M | 12.80 | |
Amicus Therapeutics (FOLD) | 6.3 | $144M | 10M | 14.39 | |
Puma Biotechnology (PBYI) | 3.9 | $90M | 914k | 98.85 | |
Clovis Oncology | 3.9 | $90M | 1.3M | 68.00 | |
Wave Life Sciences (WVE) | 3.4 | $78M | 2.2M | 35.10 | |
Alder Biopharmaceuticals | 3.2 | $75M | 6.5M | 11.45 | |
AstraZeneca (AZN) | 3.1 | $70M | 2.0M | 34.70 | |
Insmed (INSM) | 3.1 | $70M | 2.2M | 31.18 | |
ImmunoGen | 3.0 | $70M | 11M | 6.41 | |
Celgene Corporation | 3.0 | $68M | 653k | 104.36 | |
Seattle Genetics | 2.7 | $62M | 1.2M | 53.50 | |
Penumbra (PEN) | 2.5 | $58M | 617k | 94.10 | |
Centene Corporation (CNC) | 2.4 | $55M | 542k | 100.88 | |
Abbott Laboratories (ABT) | 2.2 | $51M | 897k | 57.07 | |
Atara Biotherapeutics (ATRA) | 2.2 | $51M | 2.8M | 18.10 | |
Livanova Plc Ord (LIVN) | 2.1 | $49M | 616k | 79.92 | |
Regenxbio Inc equity us cm (RGNX) | 2.1 | $47M | 1.4M | 33.25 | |
Inc Resh Hldgs Inc cl a | 2.0 | $47M | 1.1M | 43.60 | |
Bluebird Bio (BLUE) | 2.0 | $46M | 260k | 178.10 | |
Irhythm Technologies (IRTC) | 2.0 | $46M | 815k | 56.05 | |
Teleflex Incorporated (TFX) | 1.9 | $43M | 173k | 248.82 | |
Catalent (CTLT) | 1.5 | $34M | 833k | 41.08 | |
Fate Therapeutics (FATE) | 1.5 | $33M | 5.5M | 6.11 | |
UnitedHealth (UNH) | 1.4 | $33M | 149k | 220.46 | |
Oxford Immunotec Global | 1.4 | $32M | 2.3M | 13.97 | |
Glycomimetics (GLYC) | 1.4 | $32M | 1.9M | 16.79 | |
Endologix | 1.4 | $32M | 5.9M | 5.35 | |
ICU Medical, Incorporated (ICUI) | 1.3 | $30M | 140k | 216.00 | |
Xencor (XNCR) | 1.3 | $30M | 1.4M | 21.92 | |
WellCare Health Plans | 1.3 | $29M | 144k | 201.11 | |
Audentes Therapeutics | 1.3 | $29M | 929k | 31.25 | |
eHealth (EHTH) | 1.2 | $27M | 1.6M | 17.37 | |
Allscripts Healthcare Solutions (MDRX) | 1.1 | $26M | 1.8M | 14.55 | |
Universal Health Services (UHS) | 1.1 | $25M | 217k | 113.35 | |
Epizyme | 1.1 | $24M | 1.9M | 12.55 | |
Anaptysbio Inc Common (ANAB) | 1.0 | $23M | 230k | 100.72 | |
Pra Health Sciences | 1.0 | $23M | 251k | 91.07 | |
Nightstar Therapeutics | 0.9 | $22M | 1.8M | 12.33 | |
Array Biopharma Inc bond | 0.9 | $22M | 19M | 1.14 | |
Invitae (NVTAQ) | 0.9 | $20M | 2.2M | 9.08 | |
Cymabay Therapeutics | 0.8 | $18M | 2.0M | 9.20 | |
Inflarx Nv (IFRX) | 0.8 | $18M | 857k | 20.95 | |
Chimerix (CMRX) | 0.8 | $18M | 3.8M | 4.63 | |
Newlink Genetics Corporation | 0.7 | $17M | 2.1M | 8.11 | |
Heska Corporation | 0.7 | $16M | 196k | 80.21 | |
Odonate Therapeutics Ord | 0.7 | $15M | 597k | 25.00 | |
Deciphera Pharmaceuticals (DCPH) | 0.6 | $15M | 684k | 21.43 | |
Model N (MODN) | 0.6 | $13M | 854k | 15.75 | |
Argenx Se (ARGX) | 0.6 | $13M | 200k | 63.14 | |
Jounce Therapeutics | 0.5 | $13M | 980k | 12.75 | |
Transenterix | 0.4 | $9.7M | 5.0M | 1.93 | |
Cytomx Therapeutics (CTMX) | 0.4 | $8.8M | 419k | 21.11 | |
Globus Med Inc cl a (GMED) | 0.4 | $8.6M | 209k | 41.10 | |
Syros Pharmaceuticals | 0.3 | $6.2M | 637k | 9.73 | |
Teladoc (TDOC) | 0.2 | $5.2M | 150k | 34.85 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $5.0M | 1.6M | 3.23 | |
Petiq (PETQ) | 0.2 | $4.9M | 224k | 21.84 | |
Ovid Therapeutics (OVID) | 0.1 | $3.1M | 313k | 9.87 | |
Aclaris Therapeutics (ACRS) | 0.1 | $2.6M | 107k | 24.66 | |
Cascadian Therapeutics | 0.1 | $2.4M | 649k | 3.70 | |
BioMarin Pharmaceutical (BMRN) | 0.0 | $223k | 2.5k | 89.20 | |
Humana (HUM) | 0.0 | $248k | 1.0k | 248.00 | |
Align Technology (ALGN) | 0.0 | $253k | 1.1k | 221.93 | |
Nektar Therapeutics (NKTR) | 0.0 | $318k | 5.3k | 59.70 | |
Pacira Pharmaceuticals (PCRX) | 0.0 | $237k | 5.2k | 45.66 | |
Vocera Communications | 0.0 | $212k | 7.0k | 30.29 | |
Horizon Pharma | 0.0 | $292k | 20k | 14.60 | |
Castlight Health | 0.0 | $38k | 10k | 3.71 | |
Adverum Biotechnologies | 0.0 | $78k | 22k | 3.51 |